Ad Header



The Pulse of the Pharmaceutical Industry

Ad Right Top

Latest News

Hikma’s U.S. unit raises medicine prices

Hikma Pharmaceuticals Plc's U.S. subsidiary raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported.

Bayer, J&J win another Xarelto U.S. trial

A federal jury cleared Bayer and J&J of liability in the third case to go to trial out of thousands of lawsuits claiming their blood thinner Xarelto led to severe internal bleeding.

Insys agrees to resolve Illinois opioid lawsuit

Insys Therapeutics Inc. agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2017 Focus: Pharma Innovators, Top 200 Meds, Lions Health and more!


Ad Right Bottom

Main Navigation